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Abstract.  When loaded alongside GTP-7-S into ATP- 
permeabilized cells, neomycin, at concentrations below 
1 mM,  inhibits GTP-3,-S-induced histamine  secretion 
and phosphatidic  acid formation (Cockcroft, S., and 
B. D.  Gomperts,  1985.  Nature (Lond.).  314:  534-536; 
Aridor,  M., L.  M.  Traub,  and R. Sagi-Eisenberg. 
1990.  J.  Cell Biol. 111:909-917).  However, at higher 
concentrations internally applied neomycin induces 
histamine  secretion in a process that is:  (a) dose de- 
pendent;  (b) dependent on the internal  application of 
GTP;  (c) independent of phosphoinositide breakdown; 
and (d) inhibited by pertussis toxin (PtX) treatment. 
These results indicate that neomycin can stimulate 
histamine  secretion in a  mechanism that bypasses 
phospholipase C  (PLC) activation and yet involves a 
PtX-sensitive GTP-binding protein (G protein).  Unlike 
its dual effects, when internally  applied, neomycin in- 
duces histamine  secretion from intact mast cells in a 
dose-dependent manner.  Half-maximal and maximal 
effects are obtained at 0.5 and  1 mM neomycin, 
respectively. This process is rapid (,o30 s), is inde- 
pendent of external Ca  2+, and is associated with phos- 
phatidic acid formation,  implying that neomycin can 
activate histamine  secretion by a mechanism similar to 
that utilized by other basic secretagogues of mast 
cells.  Neomycin stimulates fourfold the GTPase activ- 
ity of cholate-solubilized rat brain membranes in a 
PtX-inhibitable manner.  In addition neomycin, as well 
as the basic secretagogues of mast cells, compound 
48/80, and mastoparan,  significantly reduce (by 
,080%) the ADP ribosylation of PtX substrates pres- 
ent in rat brain-membranes.  Taken together these data 
suggest that neomycin can stimulate secretion from 
mast cells by directly activating G proteins that play a 
role in stimulus-secretion coupling. When internally 
applied,  neomycin presumably stimulates secretion by 
activating a G protein that is located downstream to 
PLC.  This G protein serves as a  substrate for PtX. 
H 
ISTAMINE secretion from rat peritoneal mast cells 
can be triggered  by the introduction  of nonhydro- 
lyzable analogues  of GTP,  such as GTP-3,-S, into 
cells  permeabilized  with  ATP  (Gomperts,  1983).  Under 
these conditions secretion is associated with phosphatidic 
acid (PA)  ~ formation,  and both processes, histamine  secre- 
tion  (Cockcroft and  Gomperts,  1985)  and  PA  formation 
(Aridor et al., 1990), are inhibited by the introduction  of the 
positively charged aminoglycoside antibiotic  neomycin into 
the ATP-permeabilized  cells.  Neomycin is known to bind 
strongly and selectively to inositol  phospholipids  (Schacht, 
1978), thereby leading to inhibition  of their metabolism. It 
therefore appears that the persistent activation of a G protein 
that is coupled to a phosphoinositide-hydrolyzing  phospholi- 
pase C (PLC) (Gp) brings about histamine  secretion.  How- 
ever, GTP and its analogues do not affect the activity of Gp 
exclusively.  Mast cells,  permeabilized with streptolysin-O, 
which generates membrane lesions permitting  the efflux of 
cytosolic components,  are capable of responding to GTP-y-S 
1. Abbreviations used in this paper: PA, phosphatidic acid; PLC, phospholi- 
pase C; PtX, pertussis toxin. 
and secreting  histamine  also in the presence of neomycin 
(Howell et al., 1987). Thus, the activation of a G protein in- 
volved at a late stage in the stimulus-secretion  process (G~) 
seems to provide a sufficient signal  for exocytosis. 
Histamine secretion from rat peritoneal mast cells can be 
activated by a family of basic compounds such as compound 
48/80 (Ennis  et al.,  1980),  substance P  (Fewtrell et al., 
1982), and histone (Sagi-Eisenberg  et al.,  1985). We have 
demonstrated (Aridor et al.,  1990) that the basic secreta- 
gogues,  compound 48/80 and mastoparan,  are capable of 
stimulating secretion from ATP-permeabilized ceils in a pro- 
cess that is not accompanied by PA formation  but is depen- 
dent on the internal  application  of GTP.  We could further 
demonstrate that compound 48/80,  like mastoparan (Higa- 
shijima et al.,  1988), is capable of directly stimulating  the 
GTPase activity of G proteins in a cell-free system.  Based 
on these results,  we proposed that  basic secretagogues of 
mast cells may directly activate a G protein that  is located 
downstream  from PLC (Gs), thereby inducing  secretion in 
a mechanism  that bypasses PLC activation. 
Neomycin has previously been shown to manifest biologi- 
cal effects on cells, in addition to its known inhibitory action 
on phosphoinositide  metabolism. For example,  depending 
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tion,  aggregation responses,  and arachidonic acid release 
from semi-permeabilized platelets (Nakashima et al., 1987; 
Polascik et al., 1987).  Neomycin was also shown to modify 
the activity of human platelet membrane GTPase (Hermann 
and Jakobs, 1988) and to induce high-affinity  agonist binding 
of G  protein-coupled  receptors  (Hermann et al.,  1989). 
Therefore, to further investigate our hypothesis, in this study 
we have examined whether neomycin may activate secretion 
from mast cells in a mechanism that is independent of phos- 
phoinositide breakdown.  Indeed, we  show that neomycin 
acts as a potent secretagogue of mast cells by directly activat- 
ing G proteins involved in exocytosis. 
Materials and Methods 
Materials 
[32p]Orthophosphate  (9,400  Ci/mmol) was purchased from the Nuclear 
Center (Negev,  Israel).  [a-32p]GTP  (3,000  Ci/mmol) and [c~-32p]NAD 
(800 Ci/mmol) were from New England Nuclear (Boston,  MA). Pertussis 
toxin (Ptx) was from List Biological Laboratories (Campbell, CA). Unless 
otherwise specified, all reagents were from Sigma Chemical Co. (St. Louis, 
MO). Neomycin and neomycin analogues were in their sulfate salt forms. 
Cells 
Mast cells from the peritoneal cavity of male Wistar rats (250-300 g body 
weight) were isolated and purified over a Ficoll gradient as previously de- 
scribed (Sngi-Eisenberg et ai., 1983). Purity of the cell population was de- 
termined using tohidine blue staining and cell viability was determined 
using trypane blue exclusion.  Under these conditions a homogeneous mast 
cell population was obtained (>90%) with 95% viability. 
Cell PermeabUization 
Purified mast cells were permeabilized as described in Aridor et al. (1990). 
Histamine Secretion 
Histamine secretion was measured as previously described (Sagi-Eisenberg 
et ai.,  1983). 
Phospholipid Analysis 
Analysis of phospholipids was carried out as described in Aridor et al. 
(1990). 
Membrane Preparation 
Rat brain membranes were prepared according to Katada et al. (1986). 
GTPase Assay 
The GTPase assay was performed according to Gibbs et ai. (1988). 30-#g 
aliquots of cholate solubilized rat brain membranes were incubated in the 
presence of the indicated reagents  for 5 min at 25°C in a final volume of 
100 #1. The reaction mixture contained final concentrations  of  0.1 mM ATP, 
0.2  raM  ATP~-S,  0.3  #M GTP,  0.1  mM EGTA,  1 mM  DTT,  2  ram 
MgAc2,  5  mM  phosphocreatine,  0.4  mg/ml  creatine  ldnas¢,  20  mM 
Tris.HC1,  pH 7.4,  and 0.1 /~Ci of [a-32p]GTP.  Reaction was stopped by 
spotting 5-#1 aliquots onto poly(ethylane)imine-cellulose TLC plates.  The 
plates were developed with 1 M KH2PO4, pH 4.5, and visualized by auto- 
radiography. The spots corresponding to GDP were analyzed by Molecular 
Dynamics Computing Densitometty (Sunnyvale, CA). Specific GTPase ac- 
tivity was calculated from the difference between [32p]GDP released in the 
absence or presence of 100 #M GTP. 
ADP  Ribosylation 
Cholate-solubilized rat brain membranes (80 #g) were incubated for 30 rain 
at 30°C in the presence of 1 mM ATE 15 mM thymidine, 100 mM potas- 
slum phosphat  e buffer, pH 7.5, 3 mM DTT, 20 #M [a-32P]NAD (1 #Ci), 
and 1 ~g of preactivated PtX. Reaction was stopped by adding concentrated 
Laemmli:sample  buffer. Samples were analyzed by SDS-PAGE and autora- 
diography  of the gels. 
Presentation of Data 
Tiie data points presented are means of duplicate determinations that did 
not vary by more than 2 %.  Similar results were obtained on at least two 
occasions. 
Results 
Effect of Neomycin on Histamine Secretion from 
Intact Mast Cells 
Addition of neomycin at concentrations >0.4 mM to intact, 
purified rat peritoneal mast cells resulted in their degranula- 
tion as evidenced by the secretion of  the two granular compo- 
nents histamine (Fig.  1 A) and the enzyme/~-hexosaminidase 
(not shown). A concentration of 1 mM neomycin stimulated 
secretion of 50%  of the  granular content,  while a  half- 
maximal effect was achieved at a concentration of 0.5 mM 
neomycin (Fig. 1 A). 
Histamine secretion induced by neomycin did not require 
the  presence  of exogenous  Ca  2÷.  In  fact,  as  previously 
found for other positively charged secretagogues such as 
compound 48/80 (Atkinson et al.,  1979)  and substance P 
(Fewtrell et al., 1982),  Ca  2+ antagonized neomycin-induced 
secretion and this inhibitory effect could only be overcome 
in the presence of supermaximal concentrations of neomycin 
(Fig. 1 A). Mg  2÷ also had a small inhibitory effect on the in- 
duced release.  However,  this effect was significant only at 
submaximal concentrations of neomycin (Fig.  1 A).  The 
most pronounced effect was exerted by Mn  2÷, which com- 
pletely abolished neomycin-induced secretion (Fig.  1 A). 
Both Ca  2+ and Mn  2÷ inhibited secretion induced by an op- 
timal concentration of neomycin (1.5 mM) in a dose-depen- 
dent manner (Fig. 1 B). Maximal inhibition (90%) was ob- 
tained at concentrations of 1 mM Mn  2* and 2  mM Ca  2*, 
while half-maximal inhibition was exerted by concentrations 
of 0.2 mM Mn  2+ and 0.7 mM Ca  2÷ (Fig.  1 B). At this neo- 
mycin concentration  Mg  :+ had no inhibitory effect (Fig.  1 B). 
Neomycin-induced secretion was rapid and virtually com- 
plete within 30 s of adding neomycin (Fig. 1 C). The release 
showed similar kinetics when measured at different neomy- 
cin concentrations (not shown). 
•  Effect of  Neomycin Analogues on Histamine Secretion 
from Intact Mast Cells 
Three other aminoglycoside antibiotics, related to neomy- 
cin, were also tested for their ability to induce secretion from 
intact mast cells. Oentamycin and paromomycin, which in- 
clude five of the six amino groups present in neomycin (Fig. 
2 A) stimulated secretion to a similar extent (60%.) in a dose- 
dependent fashion (Fig. 2 B). Nevertheless, while compara- 
ble in their relative potencies, both gentamycin and paromo- 
mycin were less effective than neomycin when compared on 
a molar basis. Their maximal effects were achieved at con- 
centrations of 1.5 and 2 mM and their half-maximal effects 
at 1.0 and 1.2 mM gentamycin and paromomycin, respec- 
tively.  Another analogue of neomycin, geneticin (G-418), 
which contains only three amino groups (Fig. 2 A), was corn- 
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Figure 1. (A) Neomycin-induced histamine secretion from intact 
mast cells.  Mast cells were incubated  for 20 rain at 30°C with the 
indicated  concentrations of neomycin in the absence (n) or pres- 
ence of 2.5 mM Mg  2÷ (m), Ca  2+ (,), and Mn  2+. The reaction was 
stopped and histamine secretion was determined as described in 
Materials  and Methods.  (B) Effect of  divalent cations on neomycin- 
induced histamine secretion.  Mast cells were incubated for 20 rain 
at 30°C in the presence of 1.5 mM neomycin and the indicated con- 
centrations of Mn  2+ (~),  Ca  2+ ([]),  and Mg  2+ (I).  The reaction 
was stopped and histamine secretion was determined as described 
in Materials and Methods. (C) Kinetics of neomycin-induced hista- 
mine secretion.  Mast cells were incubated with 5 mM neomycin for 
the indicated  time periods.  Reaction  was stopped and histamine 
secretion  was determined as described in Materials  and Methods. 
pletely ineffective and failed to induce secretion (Fig. 2 B) 
even when tested at concentrations up to 7 mM (not shown). 
Hence,  a  correlation  seems  to  exist  between  the positive 
charge of the agonist tested and its potency in inducing the 
secretory response. 
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Figure 2. (A) Structure of neomycin analogues. (B) Effect of neo- 
mycin analogues on histamine  secretion.  Mast cells were incubat- 
ed for 20 rain at 30°C with the indicated  concentrations of neo- 
mycin ([]),  gentamycin (,),  paromomycin (0),  and  geneticin 
G-418 (,,).  The reaction was stopped and histamine secretion was 
determined as described in Materials  and Methods. 
Effect of  Neomycin on PA Formation 
Histamine  secretion induced by neomycin involved the ac- 
tivation of a phospholipase leading to PA formation. This is 
illustrated  in Fig.  3, where,  similarly to the effect of com- 
pound 48/80 that stimulated eighffold PA formation (lanes c 
and c', compared with a  and a~, the addition of 5 mM neo- 
mycin to 32p-labeled cells resulted in 3.6-fold enhancement 
of the formation of [32p]PA (lanes b  and b', compared with 
a and a'). This increase in PA probably reflected a rise in di- 
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Figure 4.  Effect of GTP on 
neomycin-induced  histamine 
secretion from permeabilized 
mast ceils. Purified mast cells 
were  permeabilized  as  de- 
scfibed in Materials and Meth- 
ods  in  the  presence  of  the 
indicated  concentrations  of 
neomycin  and  the  presence 
(e) or absence  (o) of 1 ram 
GTP. Ceils were subsequently 
2  3  4  5  resealed and histamine Secre- 
[neomycin] (raM)  tion was determined. 
Figure 3.  Effect of neomycin  on PA formation  by intact  mast 
cells.  Purified mast ceils (1  x  10  ~ cells/ml)  were incubated for 
2  h  at  30oc  with  32Pi (100  tLCi/ml). Cells  were  subsequently 
washed  and incubated for 20 min at 30°C  in a Ca2+-containing 
buffer in the absence (lane a) or presence of neomycin (5 mM; lane 
b)  or 48/80  (10 t~g/ml; lane  c).  Reaction  was  stopped  and  PA 
formed was determined  as described  in Materials  and Methods. 
The spots corresponding to PA were cut and counted by Cernekov 
(lanes a'-c', respectively).  The results of a representative experi- 
ment are presented.  Similar  results were  obtained  on three oc- 
casions. 
acylglycerol levels due to a stimulated metabolism of inositol 
phospholipids. This is suggested by the finding that PA for- 
mation  was  not  stimulated  in  neomycin-treated cells  into 
which neomycin had been introduced by ATP permeabili- 
zation. 
These results, therefore, indicate that when added to intact 
cells  neomycin  interacts  with  a  membrane  component, 
which eventually activates a PLC leading to phosphoinosi- 
tide breakdown and histamine secretion. In contrast, when 
loaded into the cells neomycin binds to the inositol phospho- 
lipids present in the inner leaflet of the membrane, thereby 
causing the inhibition of phosphoinositide metabolism. 
Effect of Neomycin on Histamine Secretion from 
ATP-permeabilized  Cells 
We have previously shown (Aridor et al.,  1990) that com- 
pound 48/80 can trigger secretion from ATP-permeabilized 
and resealed mast cells in a process that is independent of 
PLC activation, but requires the internal application of GTP. 
To determine whether neomycin could act in a similar man- 
ner,  histamine  secretion was studied  in cells loaded with 
neomycin under conditions that completely block PLC acti- 
vation.  As illustrated  in Fig.  4,  neomycin introduced into 
ATP-permeabilized mast cells was still capable of stimulat- 
ing histamine secretion in a mechanism that was independent 
of phosphoinositide  metabolism.  However,  unlike  the  re- 
lease from intact cells (Fig.  1 A), higher concentrations of 
neomycin  were  required  to  elicit  secretion  from  ATP- 
permeabilized cells. 
The dose-response curve for neomycin could be shifted 
leftwards by introducing  1 mM GTP into the cells during 
their permeabilization. In the presence of GTP the effective 
concentration of neomycin required to induce secretion was 
similar to that of intact cells, and maximal secretion was ob- 
tained with 1 mM neomycin (Fig. 4). This result, therefore, 
indicates that diminution of intracellular GTP inhibits the 
cell's responsiveness to neomycin treatment. 
Effect of  PtX on Histamine Secretion Induced by 
Loaded Neomycin 
The dependency of loaded neomycin on the presence of in- 
tracellular GTP to elicit secretion suggests that the internally 
applied neomycin can trigger secretion by activating a G pro- 
tein that is located at a step distal to PLC. A plausible candi- 
date is the previously suggested GE protein (Barrowman et 
al.,  1986).  To determine whether GE is a PtX substrate, we 
have analyzed the sensitivity of histamine release, induced 
by loaded neomycin, to PtX treatment. 
As shown in Fig. 5, release induced by entrapped neomy- 
cin retained its sensitivity to PtX treatment. Cells that were 
ATP-permeabilized and loaded with  1 mM neomycin after 
2 h of treatment with 100 ng/ml PtX secreted only 40% of 
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Figure  5.  Effect  of  PtX  on 
neomycin-induced  histamine 
secretion from permeabilized 
cells. Purified mast cells (1  x 
106 cells/ml)  were  incubated 
for 2 h at 30°C with (b, d, f) 
or without (a, c, e) PtX (100 
ng/rrd). The cells were washed 
and perrneabilized  for 6 rain 
in the presence  (a, b) or ab- 
sence (c-f) of 1 mM neomy- 
cin. The cells were subsequently resealed and further incubated for 
20 rain with compound  48/80  (5 /~g/ml) (c, d),  or mastoparan 
(100/~M) (e, f). The reaction was stopped and histamine secretion 
was determined. The mean values of  duplicate determinations  +SE 
are presented.  Similar results were obtained  on two occasions. 
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a and b). Under the same conditions the cell responsiveness 
to two other basic secretagogues, compound 48/80 (5 #g/ml; 
Fig. 5, lanes c and d) and mastoparan (100 #M; Fig. 5, lanes 
e  and f) was lowered by a  similar degree. These results, 
therefore, suggest that GE is a PtX substrate. 
Effect of  Neomycin on GTPase Activity of 
Rat Brain Membranes 
We have previously shown (Aridor et al.,  1990) that com- 
pound 48/80,  like mastoparan (Higashijima et al.,  1988), 
can stimulate the GTPase activity of cholate-solubilized rat 
brain membranes.  We have, therefore, examined whether 
neomycin can also stimulate GTPase activity under these 
conditions. Neomycin, like mastoparan, stimulated three- to 
fourfold the GTPase activity of cholate-solubilized rat brain 
membranes (Table  I).  Furthermore, this stimulatory effect 
was significantly reduced when the membranes were sub- 
jected to ADP ribosylation by PtX before the GTPase assay 
(Table I). These results, therefore, indicate that neomycin is 
capable of directly activating G proteins. 
Effect of  Basic Secretagogues on PtX-catalyzed 
ADP Ribosylation 
PtX-catalyzed  ADP-ribosylation of G  protein  ~-subunits 
reflects the state of  activation of  the (3 protein. Since it is only 
the inactive, holo (3 protein that serves as a  substrate for 
ADP ribosylation by PtX, we examined the ability of  the ba- 
sic  secretagogues mastoparan,  neomycin, and  compound 
48/80 to alter ADP ribosylation. 
PtX catalyzed the ADP ribosylation of proteins in the 40- 
kD range (Fig. 6, lanes b and c compared with a). Despite 
the apparent homogeneity of the PtX-labeled band on SDS- 
PAGE,  this band represents several  substrates for PtX that 
are  present  in  rat  brain  membranes.  Including  100  ttM 
mastoparan (Fig. 6, lane d), 2.5 or 5 mM neomycin (lanes 
e and  f, respectively); or 0.5, 1, or 2 #g/ml compound 48/80 
(lanes  g,  h,  and  i,  respectively)  in  the  reaction  mixture 
resulted in decreased ADP ribosylation. At a concentration 
of 5 mM neomycin, ribosylation was inhibited ,u80% (Fig. 
6, lanefcompared with lanes b and c). These results, there- 
fore, further suggest that these basic secretagogues enhanced 
subunit dissociation and activation of G proteins. 
Discussion 
Previous studies have indicated the involvement of a GTP- 
Table L Activation of  GTPase Activity 
Figure 6.  Effect of basic secretagogues of mast cells on PtX- 
catalyzed ADP ribosylation. Cholate-solubilized rat brain mem- 
branes (80-#g aliquots) were ADP ribosylated in the absence (a) 
or presence (b-0 of  activated  PtX (10 #g/ml) and the following  rea- 
gents: none (b, c),  100 ttM mastoparan (d), 2.5 and 5 mM neo- 
mycin (e and f, respectively), 0.5, 1, and 2, ttg/ml compound 48/ 
80 (g, h, and i, respectively). The results of a representative ex- 
periment are presented.  Similar results were obtained on four 
occasions. 
binding protein (GB), located distal to PLC, in exocytosis 
of mast cells (Howell et al.,  1987).  It appears  that G~ is 
normally inhibited by an as yet unknown inhibitory factor. 
Unless activated either by the dialysis of this factor in patch 
clamped cells (Fernandez et al., 1984) or by some physiolog- 
ical, yet unidentified modulators, GE fails to bind GTP or 
GTP--y-S and activate exocytosis. 
We have previously shown (Aridor et al.,  1990)  that the 
basic secretagogues, compound 48/80 and mastoparan, can 
stimulate secretion in a mechanism that bypasses PLC acti- 
vation but involves activation of a (3 protein. We (Aridor et 
al.,  1990)  and others (Mousli et al.,  1990)  could further 
demonstrate that compound 48/80, like mastoparan (Higa- 
shijima et al., 1988),  can directly stimulate the GTPase ac- 
tivity of G proteins. Based on these and other studies (Repke 
et al.,  1987),  we suggested that molecules whose structure 
involves positive charges associated with a hydrophobic do- 
main and that can be inserted into the lipid bilayer (mastopa- 
ran,  compound 48/80,  substance P),  or a  high density of 
[32p]GDP formed*  (arbitrary units) 
Experiment 1  Experiment II 
Control membranes~  t  Control membranes  PtX-treated  membranes 
None  1,489  +  85  1,500  +  100  1,500  +  500 
Neomycin (5  raM)  5,500  +  500  7,000  +  530  3,300  +  825 
Mastoparan (100 ttM)  2,570  +  390  ND  ND 
Rat brain membranes (4.5 mg/ml) were solubilized with 1% cholate and incubated for 1 h at 30"C with the ADP ribosylation reaction mixture described in Materials 
and Methods in the absence (control membranes) or presence (PtX-treated)  of activated PtX (5 ~tg). Aliquots (30/~g) were then added to the GTPase reaction mixture 
and the GTPase activity was determined as described in Materials and Methods. 
* Spots corresponding to [32p]GDP formed were analyzed by Molecular Dynamics Computing densitometry. Values obtained in the preSence of 0.1 mM GTP were 
subtracted. 
*  The results presented are means of duplicate determinations :I:SE of two representative experiments. Similar results were obtained on six occasions. 
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brane structure (Sande and  Mandell,  1985),  may activate 
secretion  in a receptor-independent manner.  This secretion 
is mediated by directly activating G proteins.  Therefore,  by 
directly activating the putative GE protein these agents may 
stimulate  secretion that is independent  of phosphoinositide 
breakdown.  In this study we have further challenged this hy- 
pothesis by testing the ability of neomycin to stimulate secre- 
tion. We postulated that this positively charged aminoglyco- 
side may activate secretion in a mechanism that is similar to 
that utilized by other polybasic molecules.  Indeed, here we 
demonstrate that neomycin added to intact cells induces their 
degranulation  in a process that is rapid, does not require the 
presence of external  Ca  2÷, and is associated with phospho- 
inositide breakdown (Figs. 1 and 3). Based on these criteria, 
it appears that neomycin and the previously reported family 
of basic secretagogues  of mast cells release histamine  by a 
common mechanism. 
Our results  further  demonstrate that  caution should  be 
taken when using neomycin as a selective inhibitor  of phos- 
phoinositide  hydrolysis  (Siess  and Lapetina,  1986;  Naka- 
shima  et al.,  1987; Polascik et al.,  1987; Hermann et al., 
1989).  When added to intact cells, neomycin  earl clearly 
interact  with a membrane component that eventually  acti- 
vates phosphoinositide  breakdown and histamine  secretion. 
This membrane component could be a receptor for polybasic 
secretagogues.  However,  since receptors for polybasic se- 
cretagogues have not been identified yet, while basic secre- 
tagogues such as mastoparan  (Higashijima  et al.,  1988), 
compound 48/80 (Axidor et al., 1990; Mousli et al., 1990), 
and neomycin (Hermann and Jakobs, 1988) (Table I) stimu- 
late GTPase activity of G proteins,  these data strongly sug- 
gest that this  class of secretagogues triggers  secretion by 
directly activating  G proteins that play a role in the stimu- 
lus-secretion  coupling. 
Sialic acid residues or acidic phospholipids  are probably 
the  putative  targets  for binding  these  polybasic secreta- 
gogues (Shibata et al., 1984, 1985). After their primary in- 
teraction  with negatively  charged  sites  in the membrane, 
these basic secretagogues might be inserted into the mem- 
brane,  allowing  the activation  of PtX-sensitive  G proteins 
(Wakamatsu et al.,  1983). The degree of amphiphilicity  of 
a certain secretagogue will thus be an important factor in 
defining its specific interaction  with the membrane and the 
extent  of its  insertion  into  the  membrane  (Sargent  and 
Schwyzer,  1986).  The somewhat slower rate of histamine 
secretion induced  by neomycin  (~30  s;  Fig.  1 C)  when 
compared with secretion induced  by 48/80 or mastoparan 
(*10 s) may reflect the lower amphiphilicity  of neomycin. 
Further support to this notion comes from the observation 
that  the potency of neomycin  and three related  analogues 
(gentamycin,  paromomycin, and geneticin  G-418)  in stim- 
ulating the secretory response is correlated with the degree 
of their cationic  charges  (Fig. 2). In addition,  divalent cat- 
ions that are known to bind acidic phospholipids  inhibit the 
neomycin-induced  response,  probably by competing  with 
neomycin for binding  sites (Fig.  1 A). Moreover,  the effec- 
tiveness  of the divalent  cations  in inhibiting  neomycin-in- 
duced response (Fig. 1 B) is well correlated with their effec- 
tiveness in inducing aggregation of phosphatidylserine  vesi- 
cles (Mn  2+ >  Ca  2+ >  Mg  2+ ) (Ohki et al.,  1982). 
The interaction  between basic secretagogues  and G pro- 
teins  is  further  illustrated  in their  ability to inhibit  PtX- 
catalyzed ADP ribosylation.  Mastoparan, compound 48/80, 
and neomycin  all  inhibited  ADP ribosylation  of rat brain 
membrane proteins (Fig. 6). This altered susceptibility of the 
G proteins to ADP ribosylation by PtX reflects a conforma- 
tional  shift that is associated with their  activation. 
In the presence of internally  loaded neomycin (introduced 
into ATP-permeabilized  cells), phosphoinositide  hydrolysis 
is inhibited.  This inhibition  probably reflects the known ac- 
tion of neomycin that binds to inositol phospholipids,  there- 
by inhibiting  their  metabolism (Schacht,  1978). Neverthe- 
less,  under  these conditions  neomycin  is  still  capable of 
stimulating  secretion,  provided that either its concentration 
is increased to 1 mM (or above), or that 1 mM GTP is also 
entrapped in the ATP-permeabilized  cells (Fig. 4).  Hence, 
while neomycin, loaded at low concentrations  (<I mM), in- 
hibits phosphoinositide  breakdown and secretion that is de- 
pendent on PLC activation (Cockcroft and Gomperts, 1985), 
at higher concentrations  and in the presence of 1 mM GTP 
neomycin  can trigger  secretion by activating  a  G  protein 
(G~) that is located downstream from PLC. 
Together our findings  imply that  neomycin  can interact 
with more than one G protein in the signal transduction  cas- 
cade.  When applied  to intact cells neomycin  may activate 
Gp and possibly GE to stimulate  secretion that is associated 
with phosphoinositide  breakdown.  When applied  internally 
neomycin self-inhibits phosphoinositide metabolism, there- 
fore leading  to secretion that is mediated by GE only. The 
finding that under these conditions  PtX treatment  inhibits 
secretion (Fig.  5) indicates  that GE is a substrate  for ADP 
ribosylation  by PtX. 
In conclusion,  basic secretagogucs,  such as neomycin and 
mastoparan,  that block phosphoinositide breakdown by bind- 
ing to these negatively charged phospholipids  (Wojcildewicz 
and Nahorski,  1989), can be used as a tool to study the cas- 
cade of events involved m Gractivated histamine  secretion. 
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